STOCK TITAN

John Wiley & Sons, Inc. (WLY) Financials

WLY
Trailing 12 months to July 31, 2026
Revenue $1.7B -0.3% YoY
Net Income $198.2M +103.6% YoY
EPS (Diluted) $3.71 +109.6% YoY
Free Cash Flow $239.9M +62.8% YoY
Market Cap $2.6B as of Oct 13, 2026
Price / Sales 1.6x on $1.7B revenue, trailing 12 months to July 31, 2026
Price / Earnings 13.1x on $198.2M net income, trailing 12 months to July 31, 2026
Price / Book 3.3x on $797.0M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Currency USD FYE April

Newest figures come from the 10-Q for Q1 FY2027, filed Sep 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WLY SEC filings page.

John Wiley & Sons, Inc. (WLY) reported $1.7B in revenue over the twelve months to Jul 31, 2026, down 0.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WLY FY2026

Revenue has shrunk, but lower costs and a richer margin structure have made the business materially more profitable and cash generative.

By FY2026, revenue was below FY2022 levels while gross margin reached 74.3%; that combination indicates improved economics came from mix and/or cost structure, not volume growth. Operating cash flow of $260.5M exceeded net income of $221.6M, showing earnings were broadly converted into cash rather than remaining purely accounting profit.

Gross margin expansion moved from 66.4% in FY2022 to 74.3% in FY2026, despite the smaller revenue base. SG&A fell from $1.1B to $895.9M over the same span, supporting a leaner operating model rather than a sales-led improvement.

The current ratio stayed near 0.5x through FY2026, so short-term obligations remained larger than current assets. Capital spending declined across the period while free cash flow recovered to $209.4M in FY2026, indicating less reinvestment was needed to produce cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 43 / 100
Financial Health Score 43/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of John Wiley & Sons, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
66

John Wiley & Sons, Inc. has an operating margin of 16.5%, meaning the company retains $17 of operating profit per $100 of revenue. This strong profitability earns a score of 66/100, reflecting efficient cost management and pricing power. This is up from 13.2% the prior year.

Growth
15

John Wiley & Sons, Inc.'s revenue declined 0.1% year-over-year, from $1.7B to $1.7B. This contraction results in a growth score of 15/100.

Leverage
39

John Wiley & Sons, Inc. has a moderate D/E ratio of 0.79. This balance of debt and equity financing earns a leverage score of 39/100.

Liquidity
5

John Wiley & Sons, Inc.'s current ratio of 0.54 is below the typical benchmark, resulting in a score of 5/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
66

John Wiley & Sons, Inc. converts 12.5% of revenue into free cash flow ($209.4M). This strong cash generation earns a score of 66/100.

Returns
65

John Wiley & Sons, Inc. earns a strong 26.1% return on equity (ROE), meaning it generates $26 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 65/100. This is up from 11.2% the prior year.

Altman Z-Score Grey Zone
2.67

John Wiley & Sons, Inc. scores 2.67, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

John Wiley & Sons, Inc. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.18x

For every $1 of reported earnings, John Wiley & Sons, Inc. generates $1.18 in operating cash flow ($260.5M OCF vs $221.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
6.31x

John Wiley & Sons, Inc. earns $6.31 in operating income for every $1 of interest expense ($276.9M vs $43.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$386.4M
YoY-2.6%
QoQ-13.7%
5Y CAGR-4.6%
10Y CAGR-0.5%

John Wiley & Sons, Inc. generated $386.4M in revenue in Q1 2027. This represents a decrease of 2.6% from the same quarter a year earlier. Against the prior quarter it is down 13.7%.

EBITDA
$40.3M
YoY-40.3%
QoQ-72.4%
5Y CAGR-15.9%

John Wiley & Sons, Inc.'s EBITDA was $40.3M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 40.3% from the same quarter a year earlier. Against the prior quarter it is down 72.4%.

Net Income
-$11.7M
YoY-200.2%
QoQ-108.7%

John Wiley & Sons, Inc. reported -$11.7M in net income in Q1 2027. This represents a decrease of 200.2% from the same quarter a year earlier. Against the prior quarter it is down 108.7%.

EPS (Diluted)
-$0.23
YoY-204.5%
QoQ-109.1%

John Wiley & Sons, Inc. earned -$0.23 per diluted share (EPS) in Q1 2027. This represents a decrease of 204.5% from the same quarter a year earlier. Against the prior quarter it is down 109.1%.

Cash & Balance Sheet

Free Cash Flow
-$66.5M
YoY+31.5%
QoQ-146.2%

John Wiley & Sons, Inc. recorded an outflow of $66.5M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents an increase of 31.5% from the same quarter a year earlier. Against the prior quarter it is down 146.2%.

Cash & Debt
$106.4M
YoY+30.0%
QoQ+40.7%
5Y CAGR+5.1%
10Y CAGR-5.4%

John Wiley & Sons, Inc. held $106.4M in cash against $1.3B in long-term debt as of Q1 2027.

Shares Outstanding
Diluted avg 51M

John Wiley & Sons, Inc. had a weighted average of 51M diluted shares in Q1 2027; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
73.9%
YoY+1.4pp
QoQ-1.5pp
5Y change+7.9pp
10Y change+2.0pp

John Wiley & Sons, Inc.'s gross margin was 73.9% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Operating Margin
0.8%
YoY-7.0pp
QoQ-23.8pp
5Y change-7.6pp
10Y change-10.1pp

John Wiley & Sons, Inc.'s operating margin was 0.8% in Q1 2027, reflecting core business profitability. This is down 7.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 23.8 percentage points.

Net Margin
-3.0%
YoY-6.0pp
QoQ-33.2pp
5Y change-5.9pp
10Y change-10.7pp

John Wiley & Sons, Inc.'s net profit margin was -3.0% in Q1 2027, showing the share of revenue converted to profit. This is down 6.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 33.2 percentage points.

Return on Equity
-1.5%
YoY-3.1pp
QoQ-17.4pp
5Y change-2.8pp
10Y change-4.5pp

John Wiley & Sons, Inc.'s ROE was -1.5% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 17.4 percentage points.

Capital Allocation

Share Buybacks
$15.2M
YoY+12.8%
QoQ-49.4%
5Y CAGR+15.6%
10Y CAGR+3.0%

John Wiley & Sons, Inc. spent $15.2M on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents an increase of 12.8% from the same quarter a year earlier. Against the prior quarter it is down 49.4%.

Capital Expenditures
$11.2M
YoY-6.7%
QoQ-15.1%
5Y CAGR-9.0%
10Y CAGR-6.0%

John Wiley & Sons, Inc. invested $11.2M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 6.7% from the same quarter a year earlier. Against the prior quarter it is down 15.1%.

R&D Spending

Not reported for Q1 2027.

WLY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WLY quarterly income statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Revenue$386.4M-2.6%$447.9M+1.2%$410.0M+1.3%$421.8M-1.1%$396.8M-1.7%$442.6M-5.5%$404.6M-12.2%$426.6M-13.4%
Cost of Revenue$100.9M-7.7%$110.1M-0.8%$107.8M+3.4%$104.4M-2.4%$109.3M0.0%$110.9M-10.1%$104.2M-27.5%$107.0M-31.2%
Gross Profit$285.5M-0.7%$337.9M+1.9%$302.3M+0.6%$317.4M-0.7%$287.5M-2.4%$331.6M-3.9%$300.4M-5.2%$319.6M-5.2%
SG&A Expenses$238.5M-0.7%$211.4M-8.0%$219.1M-4.7%$225.1M-5.8%$240.3M-3.4%$229.8M-8.8%$230.0M-9.2%$238.9M-5.3%
Operating Income$2.9M-90.5%$110.1M+44.0%$62.8M+21.1%$73.0M+13.8%$31.0M+6.9%$76.5M+11.2%$51.8M+211.7%$64.1M+38.7%
EBITDA$40.3M-40.3%$145.7M+28.7%$98.3M+11.4%$108.9M+8.0%$67.4M+1.8%$113.2M-2.8%$88.3M+9524.2%$100.9M+16.7%
Interest Expense$13.9M+26.1%$9.6M-14.4%$11.5M-18.1%$11.7M-19.3%$11.0M-13.6%$11.3M-1.2%$14.0M+5.3%$14.5M+11.8%
Income Tax-$850K-114.2%-$40.4M-155.1%$14.7M-64.6%$13.1M+54.7%$6.0M-75.4%-$15.8M-155.1%$41.6M+2536.3%$8.5M+428.0%
Net Income-$11.7M-200.2%$135.3M+98.6%$29.7M+229.3%$44.9M+11.0%$11.7M+914.8%$68.1M+169.5%-$23.0M+79.8%$40.5M+308.1%
EPS (Basic)-$0.23-204.5%$2.59+105.6%$0.57+232.6%$0.85+13.3%$0.22+833.3%$1.26+180.0%-$0.43+79.3%$0.75+314.3%
EPS (Diluted)-$0.23-204.5%$2.54+104.8%$0.56+230.2%$0.84+13.5%$0.22+833.3%$1.24+175.6%-$0.43+79.3%$0.74+311.4%
Diluted Shares (Avg)51M-6.0%N/A53M-2.4%54M-2.4%54M-0.8%N/A54M-1.6%55M-0.5%

Not reported in any period shown, so not listed: R&D Expenses.

WLY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WLY quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Total Assets$3.1B+24.1%$2.6B-3.7%$2.6B-1.5%$2.5B-5.4%$2.5B-4.8%$2.7B-1.2%$2.6B-4.0%$2.6B-6.1%
Current Assets$438.2M+4.3%$419.7M-4.6%$411.3M+4.2%$381.2M+2.9%$420.3M+7.0%$439.9M-3.1%$394.8M+2.8%$370.3M-13.0%
Cash & Equivalents$106.4M+30.0%$75.6M-11.9%$95.1M-9.0%$67.4M-10.8%$81.8M-0.8%$85.9M+3.2%$104.5M+12.3%$75.5M-9.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$18.5M-15.8%$19.3M-15.8%$19.3M-23.8%$21.4M-21.1%$22.0M-15.1%$22.9M-12.8%$25.3M-10.8%$27.1M-10.0%
Accounts Receivable$210.7M-4.4%$244.2M+6.9%$200.2M+8.4%$209.7M+14.6%$220.3M+14.7%$228.4M+1.9%$184.7M+14.7%$183.0M+24.3%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$1.4B+24.4%$1.1B+1.0%$1.1B+5.5%$1.1B+1.3%$1.1B+1.6%$1.1B+2.8%$1.1B-1.6%$1.1B+1.9%
Total Liabilities$2.3B+30.4%$1.7B-10.1%$1.8B-5.4%$1.7B-6.9%$1.8B-7.6%$1.9B-2.3%$1.9B-2.3%$1.9B-3.0%
Current Liabilities$688.8M+6.2%$778.9M-5.1%$692.4M-3.5%$540.4M-3.8%$648.8M-5.8%$820.9M-6.0%$717.3M+0.7%$561.5M-8.0%
Non-Current Liabilities$1.6B+44.1%$964.6M-13.7%$1.1B-6.5%$1.2B-8.2%$1.1B-8.6%$1.1B+0.5%$1.2B-4.0%$1.3B-0.7%
Long-Term Debt$1.3B+56.1%$670.9M-15.0%$796.3M-9.2%$861.7M-9.4%$818.3M-10.1%$789.4M+2.9%$877.2M-2.6%$951.0M+1.4%
Total Equity$797.0M+8.7%$848.2M+12.8%$750.0M+9.4%$740.2M-2.0%$733.1M+2.7%$752.2M+1.7%$685.2M-8.4%$755.3M-12.9%
Retained Earnings$1.7B+7.9%$1.7B+9.2%$1.6B+5.1%$1.6B+1.6%$1.6B+1.4%$1.6B+0.5%$1.5B-2.2%$1.6B-7.4%

WLY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WLY quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Operating Cash Flow-$55.3M+35.0%$157.2M+4.6%$179.8M+23.0%$8.5M+261.0%-$85.0M+4.2%$150.3M-18.0%$146.2M+35.6%-$5.3M-358.7%
Depreciation & Amortization$37.3M+2.4%$35.5M-3.2%$35.6M-2.4%$35.9M-2.1%$36.4M-2.2%$36.7M-23.0%$36.5M-19.8%$36.7M-8.6%
Stock-Based Compensation$4.9M-17.4%N/A$5.3M+3.6%$5.6M-7.8%$5.9M-1.2%N/A$5.2M-18.1%$6.0M-7.2%
Capital Expenditures$11.2M-6.7%$13.2M-31.1%$12.9M-3.4%$13.1M-9.7%$12.0M-17.2%$19.1M+1.7%$13.3M-21.5%$14.5M-28.2%
Free Cash Flow-$66.5M+31.5%$144.0M+9.8%$167.0M+25.6%-$4.6M+76.7%-$97.0M+6.0%$131.2M-20.2%$132.9M+46.3%-$19.8M+7.4%
Investing Cash Flow-$465.4M-570.8%-$17.5M+28.1%-$26.8M-6.5%-$26.4M-27.7%$98.9M+515.2%-$24.3M+13.6%-$25.2M+5.2%-$20.7M+21.0%
Financing Cash Flow$552.9M+3366.8%-$158.3M-6.0%-$127.0M-42.7%$4.0M-65.6%-$16.9M-116.7%-$149.4M+8.1%-$89.0M-19.7%$11.5M-51.9%
Dividends Paid$18.2M-4.3%$18.1M-4.3%$18.5M-2.4%$18.8M-1.5%$19.0M-1.0%$18.9M-1.2%$19.0M-1.0%$19.1M-1.2%
Share Buybacks$15.2M+12.8%$30.1M+20.5%$34.9M+248.8%$21.6M+67.1%$13.5M+8.0%$25.0M+55.8%$10.0M+53.8%$12.9M+3.4%

WLY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WLY quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Gross Margin73.9%+1.4pp75.4%+0.5pp73.7%-0.5pp75.3%+0.3pp72.5%-0.5pp74.9%+1.3pp74.2%+5.4pp74.9%+6.5pp
Operating Margin0.8%-7.0pp24.6%+7.3pp15.3%+2.5pp17.3%+2.3pp7.8%+0.6pp17.3%+2.6pp12.8%+22.9pp15.0%+5.6pp
Net Margin-3.0%-6.0pp30.2%+14.8pp7.2%+12.9pp10.6%+1.2pp2.9%+3.3pp15.4%+10.0pp-5.7%+19.1pp9.5%+13.4pp
Return on Equity-1.5%-3.1pp16.0%+6.9pp4.0%+7.3pp6.1%+0.7pp1.6%+1.8pp9.1%+5.6pp-3.4%+11.9pp5.4%+7.6pp
Return on Assets-0.4%-0.8pp5.2%+2.7pp1.2%+2.0pp1.8%+0.3pp0.5%+0.5pp2.5%+1.6pp-0.9%+3.3pp1.6%+2.3pp
Current Ratio0.640.0x0.540.0x0.590.0x0.710.0x0.65+0.1x0.540.0x0.550.0x0.660.0x
Debt-to-Equity1.60+0.5x0.79-0.3x1.06-0.2x1.16-0.1x1.12-0.2x1.050.0x1.28+0.1x1.26+0.2x
Asset Turnover0.120.0x0.170.0x0.160.0x0.170.0x0.160.0x0.160.0x0.160.0x0.160.0x
FCF Margin-17.2%+7.3pp32.1%+2.5pp40.7%+7.9pp-1.1%+3.5pp-24.4%+1.1pp29.6%-5.5pp32.9%+13.1pp-4.6%-0.3pp

Note: The current ratio is below 1.0 (0.54), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
John Wiley & Sons, Inc. WLY FY2026 $1.7B $221.6M 13.2% $2.6B 43/100
John Wiley & Sons, Inc. WLYB FY2026 $1.7B $221.6M 13.2% $2.4B 43/100
New York Times Co. NYT FY2025 $2.8B $344.0M 12.2% $10.7B 68/100
Scholastic Corp SCHL FY2026 $1.6B $56.7M 3.6% $710.6M 39/100
Gannett Co., Inc. GCI FY2025 $2.3B $1.7M 0.1% $669.3M 20/100

Frequently Asked Questions

What is John Wiley & Sons, Inc.'s annual revenue?

John Wiley & Sons, Inc. (WLY) reported $1.7B in total revenue for fiscal year 2026. This represents a -0.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is John Wiley & Sons, Inc.'s revenue growing?

John Wiley & Sons, Inc. (WLY) revenue declined by 0.1% year-over-year, from $1.7B to $1.7B in fiscal year 2026.

Is John Wiley & Sons, Inc. profitable?

Yes, John Wiley & Sons, Inc. (WLY) reported a net income of $221.6M in fiscal year 2026, with a net profit margin of 13.2%.

John Wiley & Sons, Inc. (WLY) reported diluted earnings per share of $4.16 for fiscal year 2026. This represents a 171.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

John Wiley & Sons, Inc. (WLY) had EBITDA of $420.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, John Wiley & Sons, Inc. (WLY) had $75.6M in cash and equivalents against $670.9M in long-term debt.

John Wiley & Sons, Inc. (WLY) had a gross margin of 74.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

John Wiley & Sons, Inc. (WLY) had an operating margin of 16.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

John Wiley & Sons, Inc. (WLY) had a net profit margin of 13.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

John Wiley & Sons, Inc. (WLY) has a return on equity of 26.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

John Wiley & Sons, Inc. (WLY) generated $209.4M in free cash flow during fiscal year 2026. This represents a 48.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

John Wiley & Sons, Inc. (WLY) generated $260.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

John Wiley & Sons, Inc. (WLY) had $2.6B in total assets as of fiscal year 2026, including both current and long-term assets.

John Wiley & Sons, Inc. (WLY) invested $51.2M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, John Wiley & Sons, Inc. (WLY) spent $100.1M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

John Wiley & Sons, Inc. (WLY) had a current ratio of 0.54 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

John Wiley & Sons, Inc. (WLY) had a debt-to-equity ratio of 0.79 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

John Wiley & Sons, Inc. (WLY) had a return on assets of 8.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

John Wiley & Sons, Inc. (WLY) trades at 13.1x earnings, its market capitalization divided by net income of $198.2M net income, trailing 12 months to July 31, 2026. The market capitalization is $2.6B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

John Wiley & Sons, Inc. (WLY) trades at 1.6x sales, its market capitalization divided by revenue of $1.7B revenue, trailing 12 months to July 31, 2026. The market capitalization is $2.6B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

John Wiley & Sons, Inc. (WLY) has an Altman Z-Score of 2.67, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

John Wiley & Sons, Inc. (WLY) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

John Wiley & Sons, Inc. (WLY) has an earnings quality ratio of 1.18x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

John Wiley & Sons, Inc. (WLY) has an interest coverage ratio of 6.31x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

John Wiley & Sons, Inc. (WLY) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top